OnKure Therapeutics, Inc. (OKUR) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$62.95M | -15.7% |
| 2024 | -$54.39M | -47.3% |
| 2023 | -$36.93M | +31.4% |
| 2022 | -$53.85M | -35.2% |
| 2021 | -$39.82M | -103.7% |
| 2020 | -$19.55M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$62.95M | -15.7% |
| 2024 | -$54.39M | -47.3% |
| 2023 | -$36.93M | +31.4% |
| 2022 | -$53.85M | -35.2% |
| 2021 | -$39.82M | -103.7% |
| 2020 | -$19.55M | — |